On March 17th, @dano-hta.bsky.social will serve as a panelist at the NICE Conference for a session on "International collaboration to develop health technology assessment methods" with NICE's Nick Crabb, CDA's Nicole Mittmann, and Univ of York's Mark Sculpher.
Register here: bit.ly/49PQxGd
On March 11th, the Health Economics Methods Advisory Group (HEMA) will release its inaugural report: “Defining appropriate benefits for economic evaluation of health care technologies.”
HEMA will also host a webinar on the topic on March 23rd. Register now: us02web.zoom.us/webinar/regi...
ICER posted a Special Report on Entyvio; this report will be submitted to CMS as part of the 2026 public comment process defined in CMS guidance on Medicare Drug Price Negotiations for price applicability year 2028.
Read now:https://shorturl.at/Es7Vl
ICER hashtag#WeeklyView: Upcoming ICER's upcoming report for CMS, Novo’s price cuts, & Rx in State of the Union conta.cc/3OJUzar
TODAY -- join us for a public meeting to discuss treatments for IgA #nephropathy. An independent appraisal committee will review ICER's report, hear testimony from stakeholders, and deliberate on the treatments’ clinical effectiveness and value.
Register here: events.zoom.us/ev/AuoKGT8Xu...
@nicecomms.bsky.social
On March 11th, the Health Economics Methods Advisory Group (HEMA) will release its inaugural report: “Defining appropriate benefits for economic evaluation of health care technologies.”
HEMA will also host a webinar on the topic on March 23rd. Register now: us02web.zoom.us/webinar/regi...
ICER's President and CEO, Sarah K. Emond, will be speaking at #MMDC26! On March 23rd, Sarah will join John Coster, Anna Kaltenboeck, and Robert Popovian for a session titled "From Innovation to Affordability: Navigating the New Era of Drug Pricing."
Learn more: www.ahip.org/conferences/...
ICER #WeeklyView: Upcoming public meeting, FDA reversal on Moderna vaccine, & the impact of the IRA conta.cc/46OkvI9
For more information on the conference, click here: bit.ly/4iApctH
#NICEConf26
On March 17th, @dano-hta.bsky.social will serve as a panelist at the NICE Conference for a session on "International collaboration to develop health technology assessment methods" with NICE's Nick Crabb, CDA's Nicole Mittmann, and Univ of York's Mark Sculpher.
Register here: bit.ly/49PQxGd
ICER #WeeklyView: An IgA Nephropathy Evidence Report, Final Report on smoking cessation, & FDA passes on Moderna’s flu vaccine conta.cc/4amqzKp
Institute for Clinical and Economic Review Publishes Final Evidence Report on Medication for Smoking Cessation: tinyurl.com/yvchubkk
ICER's Chief Medical Officer, @davidrind.bsky.social, sat down with Bobby Dubois of the "Live Long & Well with Dr. Bobby" podcast to discuss GLP-1s for obesity management.
Listen now: podcasts.apple.com/us/podcast/6...
Institute for Clinical and Economic Review Releases Evidence Report on Therapies for IgA Nephropathy: tinyurl.com/mumdu8d9
ICER #WeeklyView: TrumpRx launch, PBM reforms, & polling on prior auth conta.cc/3M2YbDD
ICER #WeeklyView: New Governance Board member, CMS CGT Access Model, & Congress’s health care deal conta.cc/4r7k0AP
Institute for Clinical and Economic Review Names Luke Prettol to Governance Board tinyurl.com/4jj4tsbj
ICER #WeeklyView: Smoking cessation public meeting, CMS payment models, & tabelecleucel rejection conta.cc/49zIfAj
ICER #WeeklyView: ICER turns 20, remembering David Mitchell & Stuart Altman conta.cc/45GWDWg
ICER #WeeklyView: The most important ICER stories of 2025 conta.cc/3MDt6q0
Institute for Clinical and Economic Review Publishes Final Evidence Report on Treatments for Obesity: tinyurl.com/nd8y5kvv
ICER #WeeklyView: Smoking cessation Evidence Report, IgAN Draft Evidence Report & rising prescription drug costs conta.cc/4pX81Fg
Institute for Clinical and Economic Review Publishes Evidence Report on Medication for Smoking Cessation: tinyurl.com/5xuk6pza
Institute for Clinical and Economic Review Releases Draft Evidence Report on Therapies for IgA Nephropathy: tinyurl.com/ycyva2tr
ICER #WeeklyView: ICER CEO on RHV Podcast, Medicare negotiated prices, & PBM alternatives emerge conta.cc/3Mfy4ZP
ICER President and CEO Sarah K. Emond joined the @relentleshealth.bsky.social pod to discuss the tensions that exist in drug pricing and how paying for value can help fix them. Listen: cc-lnk.com/EP494.
The bonus episode talks about ICER's work and more: cc-lnk.com/EP494-BonusC....
This week ICER marks the 5-year anniversary of ICER Analytics™, our cloud-based platform that has revolutionized the ability of users to develop formularies, negotiate drug prices, and explore new ways to apply ICER’s evidence. Learn more at analytics.icer.org.
ICER #WeeklyView: ICER Analytics is 5, ICER interviewed on GLP-1 pricing, & health benefits costs to increase conta.cc/4ieQnKC
ICER #WeeklyView: This holiday season, consider donating to ICER conta.cc/4oMsVXK
